Vaccine for Lyme disease enters final stage of clinical trial
(NEW YORK) -- Researchers are one step closer to developing a vaccine for Lyme disease, which affects nearly half a million people each year in the United States, according to the U.S. Centers for Disease Control and Prevention.Pfizer, the maker of a COVID-19 vaccine,... Read More.
